Literature DB >> 25285812

Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis.

Annalese G Neuenschwander1, Khanh K Thai1, Karla P Figueroa1, Stefan M Pulst1.   

Abstract

IMPORTANCE: Repeats of CAG in the ataxin 2 gene (ATXN2) in the long-normal range (sometimes referred to as intermediate) have been identified as modifiers of amyotrophic lateral sclerosis (ALS) risk. Prior studies have used thresholding considering various cutoffs for ATXN2 repeat length.
OBJECTIVE: To calculate association between ATXN2 CAG repeat alleles and increased risk of ALS across multiple ethnic groups. DATA SOURCES: The MEDLINE database was searched for studies published by December 29, 2013, reporting ATXN2 CAG repeat length in patients with ALS and controls. STUDY SELECTION: Studies were included if they reported original data on relative risks or odds ratios (ORs) from ALS and control populations for individual ATXN2 alleles. Review articles that reported no new data were not included in the analysis. DATA EXTRACTION AND SYNTHESIS: Analysis of allele distribution was performed to ensure that all studies followed identical allele sizing. The ORs, 95% confidence intervals, and population attributable risk percentages were calculated according to standard procedures. MAIN OUTCOMES AND MEASURES: Occurrence of ALS associated with ATXN2 repeat alleles, expressed as ORs.
RESULTS: Nine studies were analyzed, including 7505 controls and 6151 sporadic ALS cases. The ALS and control cohorts were recruited from different geographical and ethnic regions including the United States, French Canada/Canada, Belgium and the Netherlands, Germany, Italy, mainland China, Turkey, and Flanders-Belgium. The ATXN2 CAG repeat lengths ranged from 13 to 39 in patients with ALS and from 13 to 34 in controls. The ORs were less than 1.00 for alleles with 25 to 28 repeats. The OR was 1.55 for 30 repeats, but this elevation was not statistically significant (95% CI, 0.88-2.73). The ORs were 2.70 (95% CI, 1.47-4.93) for 31 CAG repeats, 11.09 (95% CI, 4.16-29.57) for 32 repeats, and 5.76 (95% CI, 1.79-18.57) for 33 repeats. CONCLUSIONS AND RELEVANCE: In contrast to prior studies with smaller numbers, risk for ALS associated with long-normal alleles is complex. Alleles with 27 and 28 repeats lower ALS risk slightly. The risk for ALS increases beginning with 29 repeats and reaches a maximum at 32 and 33 repeats. Of note, alleles with repeats of these lengths are known to be predisposed to meiotic expansion to full-penetrance mutant alleles. In patients with ALS, alleles with 31 to 33 repeats may have undergone preferential expansion in motor neurons during mitosis or DNA repair. Our meta-analysis provides a framework for counseling individuals with long-normal ATXN2 repeats.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25285812      PMCID: PMC4939089          DOI: 10.1001/jamaneurol.2014.2082

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  30 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  Amyotrophic lateral sclerosis and spinocerebellar ataxia type 2 in a family with full CAG repeat expansions of ATXN2.

Authors:  Sirinan Tazen; Karla Figueroa; Justin Y Kwan; Jill Goldman; Ann Hunt; Jacinda Sampson; Laurie Gutmann; Stefan M Pulst; Hiroshi Mitsumoto; Sheng-Han Kuo
Journal:  JAMA Neurol       Date:  2013-10       Impact factor: 18.302

3.  The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect.

Authors:  Suzana Gispert; Alexander Kurz; Stefan Waibel; Peter Bauer; Inga Liepelt; Christof Geisen; Aaron D Gitler; Tim Becker; Markus Weber; Daniela Berg; Peter M Andersen; Rejko Krüger; Olaf Riess; Albert C Ludolph; Georg Auburger
Journal:  Neurobiol Dis       Date:  2011-08-25       Impact factor: 5.996

4.  ATAXIN2 CAG-repeat length in Italian patients with amyotrophic lateral sclerosis: risk factor or variant phenotype? Implication for genetic testing and counseling.

Authors:  Cinzia Gellera; Nicola Ticozzi; Viviana Pensato; Lorenzo Nanetti; Alessia Castucci; Barbara Castellotti; Giuseppe Lauria; Franco Taroni; Vincenzo Silani; Caterina Mariotti
Journal:  Neurobiol Aging       Date:  2012-03-16       Impact factor: 4.673

5.  Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.

Authors:  P Van Damme; J H Veldink; M van Blitterswijk; A Corveleyn; P W J van Vught; V Thijs; B Dubois; G Matthijs; L H van den Berg; W Robberecht
Journal:  Neurology       Date:  2011-05-11       Impact factor: 9.910

6.  Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study.

Authors:  V McGuire; W T Longstreth; L M Nelson; T D Koepsell; H Checkoway; M S Morgan; G van Belle
Journal:  Am J Epidemiol       Date:  1997-06-15       Impact factor: 4.897

7.  Occupational exposure to magnetic fields in case-referent studies of neurodegenerative diseases.

Authors:  Curtis W Noonan; John S Reif; Michael Yost; Jennifer Touchstone
Journal:  Scand J Work Environ Health       Date:  2002-02       Impact factor: 5.024

8.  Estimation of the age at onset in spinocerebellar ataxia type 2 Cuban patients by survival analysis.

Authors:  L E Almaguer-Mederos; N S Falcón; Y R Almira; Y G Zaldivar; D C Almarales; E M Góngora; M P Herrera; K E Batallán; R R Armiñán; M V Manresa; G S Cruz; J Laffita-Mesa; T M Cyuz; V Chang; G Auburger; S Gispert; L V Pérez
Journal:  Clin Genet       Date:  2009-12-02       Impact factor: 4.438

9.  ATXN2 CAG repeat expansions increase the risk for Chinese patients with amyotrophic lateral sclerosis.

Authors:  Xiaolu Liu; Ming Lu; Lu Tang; Nan Zhang; Dehua Chui; Dongsheng Fan
Journal:  Neurobiol Aging       Date:  2013-04-28       Impact factor: 4.673

10.  ATXN2 and its neighbouring gene SH2B3 are associated with increased ALS risk in the Turkish population.

Authors:  Suna Lahut; Özgür Ömür; Özgün Uyan; Zeynep Sena Ağım; Aslihan Özoğuz; Yeşim Parman; Feza Deymeer; Piraye Oflazer; Filiz Koç; Hilmi Özçelik; Georg Auburger; A Nazlı Başak
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

View more
  25 in total

1.  Association of ATXN2 intermediate-length CAG repeats with amyotrophic lateral sclerosis correlates with the distributions of normal CAG repeat alleles among individual ethnic populations.

Authors:  Hiroya Naruse; Takashi Matsukawa; Hiroyuki Ishiura; Jun Mitsui; Yuji Takahashi; Hiroki Takano; Jun Goto; Tatsushi Toda; Shoji Tsuji
Journal:  Neurogenetics       Date:  2019-03-07       Impact factor: 2.660

2.  Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.

Authors:  Jan Cendelin; Marija Cvetanovic; Mandi Gandelman; Hirokazu Hirai; Harry T Orr; Stefan M Pulst; Michael Strupp; Filip Tichanek; Jan Tuma; Mario Manto
Journal:  Cerebellum       Date:  2021-08-10       Impact factor: 3.648

Review 3.  Cerebellar pathology in motor neuron disease: neuroplasticity and neurodegeneration.

Authors:  Rangariroyashe H Chipika; Grainne Mulkerrin; Pierre-François Pradat; Aizuri Murad; Fabrice Ango; Cédric Raoul; Peter Bede
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

4.  ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion.

Authors:  Adriano Chiò; Gabriele Mora; Mario Sabatelli; Claudia Caponnetto; Christian Lunetta; Bryan J Traynor; Janel O Johnson; Mike A Nalls; Andrea Calvo; Cristina Moglia; Giuseppe Borghero; Francesca Trojsi; Vincenzo La Bella; Paolo Volanti; Isabella Simone; Fabrizio Salvi; Francesco O Logullo; Nilo Riva; Paola Carrera; Fabio Giannini; Jessica Mandrioli; Raffaella Tanel; Margherita Capasso; Lucio Tremolizzo; Stefania Battistini; Maria Rita Murru; Paola Origone; Marcella Zollino; Silvana Penco; Letizia Mazzini; Sandra D'Alfonso; Gabriella Restagno; Maura Brunetti; Marco Barberis; Francesca L Conforti
Journal:  Neurobiol Aging       Date:  2015-12-08       Impact factor: 4.673

Review 5.  Degenerative ataxias, from genes to therapies: The 2015 Cotzias Lecture.

Authors:  Stefan M Pulst
Journal:  Neurology       Date:  2016-06-14       Impact factor: 9.910

6.  The evolving genetic risk for sporadic ALS.

Authors:  Summer B Gibson; Jonathan M Downie; Spyridoula Tsetsou; Julie E Feusier; Karla P Figueroa; Mark B Bromberg; Lynn B Jorde; Stefan M Pulst
Journal:  Neurology       Date:  2017-06-22       Impact factor: 9.910

Review 7.  The epidemiology and genetics of Amyotrophic lateral sclerosis in China.

Authors:  Xiaolu Liu; Ji He; Fen-Biao Gao; Aaron D Gitler; Dongsheng Fan
Journal:  Brain Res       Date:  2018-03-01       Impact factor: 3.610

Review 8.  Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis.

Authors:  Stephen A Goutman; Orla Hardiman; Ammar Al-Chalabi; Adriano Chió; Masha G Savelieff; Matthew C Kiernan; Eva L Feldman
Journal:  Lancet Neurol       Date:  2022-03-22       Impact factor: 59.935

9.  Ataxin-2 regulates RGS8 translation in a new BAC-SCA2 transgenic mouse model.

Authors:  Warunee Dansithong; Sharan Paul; Karla P Figueroa; Marc D Rinehart; Shaina Wiest; Lance T Pflieger; Daniel R Scoles; Stefan M Pulst
Journal:  PLoS Genet       Date:  2015-04-22       Impact factor: 5.917

Review 10.  The Multiple Faces of Spinocerebellar Ataxia type 2.

Authors:  Antonella Antenora; Carlo Rinaldi; Alessandro Roca; Chiara Pane; Maria Lieto; Francesco Saccà; Silvio Peluso; Giuseppe De Michele; Alessandro Filla
Journal:  Ann Clin Transl Neurol       Date:  2017-08-10       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.